Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 2
Out of 5,033 analysts
131
Total ratings
68.48%
Success rate
165.51%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Buy | $435 → $385 | $343.18 | +12.19% | 8 | Aug 4, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $155 | $143.00 | +8.39% | 8 | May 29, 2025 | |
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $127.03 | -37.02% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $29.02 | +51.62% | 6 | May 8, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Hold | $1,200 → $1,100 | $1,357.26 | -18.95% | 8 | May 5, 2025 | |
| DHR Danaher | Maintains: Overweight | $280 → $260 | $208.39 | +24.77% | 3 | Apr 22, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $275 → $290 | $290.93 | -0.32% | 2 | Feb 6, 2025 | |
| NEO NeoGenomics | Initiates: Buy | $22 | $10.59 | +107.74% | 1 | Dec 10, 2024 | |
| DGX Quest Diagnostics | Assumes: Buy | $185 | $190.41 | -2.84% | 1 | Dec 10, 2024 | |
| HOLX Hologic | Initiates: Hold | $85 | $71.87 | +18.27% | 7 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $43 → $56 | $48.67 | +14.28% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $32.74 | +6.90% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $125 | $95.31 | +31.15% | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $13.14 | +82.65% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.98 | +102.02% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $1.11 | +170.27% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $188.60 | -24.71% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $70.20 | -54.42% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $99.50 | +15.58% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $7.90 | +153.16% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $543.84 | +19.52% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $16.71 | -46.14% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.18 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $2.20 | +445.45% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $5.90 | +916.95% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $4.19 | +448.93% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $184.14 | +111.80% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $3.04 | +492.11% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $458.47 | -56.38% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $20.14 | +19.17% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $12.93 | +248.03% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $154.54 | -54.70% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $212.05 | -43.41% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.69 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $38.11 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $14.70 | +274.15% | 1 | Jul 19, 2016 |
Waters
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $343.18
Upside: +12.19%
Agilent Technologies
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $143.00
Upside: +8.39%
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $127.03
Upside: -37.02%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $29.02
Upside: +51.62%
Mettler-Toledo International
May 5, 2025
Upgrades: Hold
Price Target: $1,200 → $1,100
Current: $1,357.26
Upside: -18.95%
Danaher
Apr 22, 2025
Maintains: Overweight
Price Target: $280 → $260
Current: $208.39
Upside: +24.77%
Labcorp Holdings
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $290.93
Upside: -0.32%
NeoGenomics
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $10.59
Upside: +107.74%
Quest Diagnostics
Dec 10, 2024
Assumes: Buy
Price Target: $185
Current: $190.41
Upside: -2.84%
Hologic
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $71.87
Upside: +18.27%
Dec 10, 2024
Assumes: Buy
Price Target: $43 → $56
Current: $48.67
Upside: +14.28%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $32.74
Upside: +6.90%
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $95.31
Upside: +31.15%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $13.14
Upside: +82.65%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.98
Upside: +102.02%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $1.11
Upside: +170.27%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $188.60
Upside: -24.71%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $70.20
Upside: -54.42%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $99.50
Upside: +15.58%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $7.90
Upside: +153.16%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $543.84
Upside: +19.52%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $16.71
Upside: -46.14%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.18
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $2.20
Upside: +445.45%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $5.90
Upside: +916.95%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $4.19
Upside: +448.93%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $184.14
Upside: +111.80%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $3.04
Upside: +492.11%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $458.47
Upside: -56.38%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $20.14
Upside: +19.17%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $12.93
Upside: +248.03%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $154.54
Upside: -54.70%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $212.05
Upside: -43.41%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $1.69
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $38.11
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $14.70
Upside: +274.15%